Stimcell Energetics (STME) Total Debt Growth (1y) (2012 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | 16.82% |
| Nov 30, 2021 | 20.95% |
| Aug 31, 2021 | 19.66% |
| May 31, 2021 | 249.90% |
| Feb 28, 2021 | 226.06% |
| Nov 30, 2020 | 203.84% |
| Aug 31, 2020 | 202.19% |
| May 31, 2020 | -39.08% |
| Feb 29, 2020 | -35.50% |
| Nov 30, 2019 | -32.89% |
| Aug 31, 2019 | -32.61% |
| May 31, 2019 | 14.77% |
| Feb 28, 2019 | 23.60% |
| Nov 30, 2018 | 42.42% |
| Aug 31, 2018 | -3.51% |
| May 31, 2018 | -2.49% |
| Feb 28, 2018 | -9.35% |
| May 31, 2017 | 11.44% |
| May 31, 2014 | 52.93% |
| May 31, 2013 | 0.00% |
| Feb 28, 2013 | 8.49% |
| Nov 30, 2012 | 8.49% |